Table 1 Participant characteristics at baseline
REHACOP group (n=52) | Control group (n=49) | P value | |||
|---|---|---|---|---|---|
Mean (95% CI) | s.d. | Mean (95% CI) | s.d. | ||
Age (years) | 39.87 (37.23 to 42.50) | 9.5 | 38.13 (36.54 to 42.36) | 10.1 | 0.831 |
Years of education (years) | 10.55 (9.26 to 11.09) | 3.29 | 10.25 (8.99 to 10.73) | 3.0 | 0.618 |
Age at the onset (years) | 24.13 (22.16 to 26.11) | 7.1 | 22.29 (20.52 to 24.07) | 6.1 | 0.169 |
Number of hospitalizations | 8.10 (6.00 to 10.20) | 7.5 | 7.08 (4.58 to 9.59) | 8.7 | 0.532 |
Gender: n (%) | |||||
Males | 36 (75.5%) | 37 (69.2%) | 0.481 | ||
Females | 16 (24.5%) | 12 (30.8%) | |||
DSM-IV-TR: n (%) | |||||
Paranoid | 35 (67.3%) | 33 (67.4%) | 0.411 | ||
Disorganized | 4 (7.7%) | 8 (16.3%) | |||
Residual | 5 (9.6%) | 2 (4.1%) | |||
Non-specified | 8 (15.4%) | 6 (12.2%) | |||
Cognitive reserve index | 0.09 (−0.16 to 0.14) | 0.8 | −0.11 (−0.34 to 0.12) | 0.8 | 0.196 |
Chlorpromazine equivalent doses (mg per day) | 497.65 (435.9 to 559.4) | 227.7 | 479.66 (402.7 to 556.7) | 275.7 | 0.755 |
